How South Korea Can Win In The Global Clinical Trial Arena
Executive Summary
South Korea remains an attractive location for clinical trials, but as seen in recent sharp increases in activity in rival Asian countries, a rapidly changing regulatory and market environment are posing challenges. Syneos Health's CSO talks to Scrip about the pros and cons of Korea as a clinical trial site versus other Asia Pacific locations, and how the country can attract further studies into the country.